Germany
· Delayed Price · Currency is EUR Bio-Gate AG Statistics
Total Valuation
Bio-Gate AG has a market cap or net worth of EUR 6.10 million. The enterprise value is 5.69 million.
| Market Cap | 6.10M |
| Enterprise Value | 5.69M |
Important Dates
The last earnings date was Tuesday, December 10, 2024.
| Earnings Date | Dec 10, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Bio-Gate AG has 9.24 million shares outstanding. The number of shares has increased by 10.00% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 9.24M |
| Shares Change (YoY) | +10.00% |
| Shares Change (QoQ) | +6.65% |
| Owned by Insiders (%) | 8.91% |
| Owned by Institutions (%) | 11.64% |
| Float | 4.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.80 |
| PB Ratio | 2.66 |
| P/TBV Ratio | 5.16 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.84 |
| EV / Sales | 0.75 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.97 |
Financial Position
The company has a current ratio of 2.48
| Current Ratio | 2.48 |
| Quick Ratio | 0.83 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -33.75 |
Financial Efficiency
Return on equity (ROE) is -68.91% and return on invested capital (ROIC) is -39.04%.
| Return on Equity (ROE) | -68.91% |
| Return on Assets (ROA) | -25.82% |
| Return on Capital (ROIC) | -39.04% |
| Revenue Per Employee | 169,132 |
| Profits Per Employee | -44,512 |
| Employee Count | 42 |
| Asset Turnover | 1.60 |
| Inventory Turnover | 2.26 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.30% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -41.30% |
| 50-Day Moving Average | 0.69 |
| 200-Day Moving Average | 0.89 |
| Relative Strength Index (RSI) | 52.18 |
| Average Volume (20 Days) | 116 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bio-Gate AG had revenue of EUR 7.61 million and -2.00 million in losses. Loss per share was -0.22.
| Revenue | 7.61M |
| Gross Profit | 3.86M |
| Operating Income | -1.97M |
| Pretax Income | -2.03M |
| Net Income | -2.00M |
| EBITDA | -1.72M |
| EBIT | -1.97M |
| Loss Per Share | -0.22 |
Balance Sheet
| Cash & Cash Equivalents | 475,997 |
| Total Debt | n/a |
| Net Cash | 475,997 |
| Net Cash Per Share | 0.05 |
| Equity (Book Value) | 2.35M |
| Book Value Per Share | 0.25 |
| Working Capital | 1.50M |
Cash Flow
In the last 12 months, operating cash flow was -1.03 million and capital expenditures -115,000, giving a free cash flow of -1.15 million.
| Operating Cash Flow | -1.03M |
| Capital Expenditures | -115,000 |
| Free Cash Flow | -1.15M |
| FCF Per Share | -0.12 |
Margins
Gross margin is 50.68%, with operating and profit margins of -25.87% and -26.32%.
| Gross Margin | 50.68% |
| Operating Margin | -25.87% |
| Pretax Margin | -26.68% |
| Profit Margin | -26.32% |
| EBITDA Margin | -22.62% |
| EBIT Margin | -25.87% |
| FCF Margin | n/a |
Dividends & Yields
Bio-Gate AG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.00% |
| Shareholder Yield | -10.00% |
| Earnings Yield | -32.83% |
| FCF Yield | -18.77% |
Stock Splits
The last stock split was on November 26, 2012. It was a reverse split with a ratio of 0.25.
| Last Split Date | Nov 26, 2012 |
| Split Type | Reverse |
| Split Ratio | 0.25 |
Scores
Bio-Gate AG has an Altman Z-Score of -0.8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.8 |
| Piotroski F-Score | n/a |